{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T14:53:43Z","timestamp":1783349623297,"version":"3.54.6"},"reference-count":27,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2019,12,4]],"date-time":"2019-12-04T00:00:00Z","timestamp":1575417600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0225701","type":"journal-article","created":{"date-parts":[[2019,12,4]],"date-time":"2019-12-04T13:28:30Z","timestamp":1575466110000},"page":"e0225701","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":7,"title":["Antiphagocytic protein 1 increases the susceptibility of Cryptococcus neoformans to amphotericin B and fluconazole"],"prefix":"10.1371","volume":"14","author":[{"given":"Muhammad","family":"Ghaffar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cody","family":"Orr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3319-6516","authenticated-orcid":true,"given":"Ginny","family":"Webb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,12,4]]},"reference":[{"issue":"1","key":"pone.0225701.ref001","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1128\/EC.05236-11","article-title":"A Flucytosine-Responsive Mbp1\/Swi4-Like Protein, Mbs1, Plays Pleiotropic Roles in Antifungal Drug Resistance, Stress Response, and Virulence of Cryptococcus neoformans","volume":"11","author":"M-H Song","year":"2012","journal-title":"Eukaryotic Cell"},{"key":"pone.0225701.ref002","doi-asserted-by":"crossref","DOI":"10.1128\/9781555818241","volume-title":"Cryptococcus neoformans","author":"A Casadevall","year":"1998"},{"issue":"8","key":"pone.0225701.ref003","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S1473-3099(17)30243-8","article-title":"Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis","volume":"17","author":"R Rajasingham","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"pone.0225701.ref004","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.idc.2006.07.001","article-title":"Cryptococcosis","volume":"20","author":"M Chayakulkeeree","year":"2006","journal-title":"Infect Dis Clin N Am"},{"issue":"3","key":"pone.0225701.ref005","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1086\/649858","article-title":"Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America","volume":"50","author":"JR Perfect","year":"2010","journal-title":"Clinical Infectious Diseases"},{"issue":"8","key":"pone.0225701.ref006","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.1128\/IAI.00297-09","article-title":"Cytokine signaling regulates the outcome of intracellular macrophage parasitism by Cryptococcus neoformans","volume":"77","author":"K Voelz","year":"2009","journal-title":"Infection and Immunity"},{"issue":"1","key":"pone.0225701.ref007","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1086\/588792","article-title":"High-dose amphotericin B with flucytosine for the treatment of cryptococcal meningitis in HIV-infected patients: a randomized trial","volume":"47","author":"T Bicanic","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"12","key":"pone.0225701.ref008","doi-asserted-by":"crossref","first-page":"e0208471","DOI":"10.1371\/journal.pone.0208471","article-title":"Fluconazole induces ROS in Cryptococcus neoformans and contributes to DNA damage in vitro","volume":"13","author":"CA Peng","year":"2018","journal-title":"PLoS One"},{"issue":"6","key":"pone.0225701.ref009","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S0966-842X(03)00117-3","article-title":"Antifungal agents: mechanisms of action","volume":"11","author":"FC Odds","year":"2003","journal-title":"Trends Microbiol"},{"issue":"2","key":"pone.0225701.ref010","first-page":"130","article-title":"Antifungal agents: mode of action in yeast cells","volume":"19","author":"AJ Carrillo-Mu\u00f1oz","year":"2006","journal-title":"Rev Esp Quimioter"},{"issue":"1","key":"pone.0225701.ref011","doi-asserted-by":"crossref","first-page":"84","DOI":"10.4049\/jimmunol.182.1.84","article-title":"App1: An Antiphagocytic Protein That Binds to Complement Receptors 3 and 2","volume":"182","author":"P Stano","year":"2009","journal-title":"The Journal of Immunology"},{"issue":"7","key":"pone.0225701.ref012","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1172\/JCI18309","article-title":"Identification of App1 as a regulator of phagocytosis and virulence of Cryptococcus neoformans","volume":"112","author":"C Luberto","year":"2003","journal-title":"J Clin Invest"},{"issue":"43","key":"pone.0225701.ref013","doi-asserted-by":"crossref","first-page":"36055","DOI":"10.1074\/jbc.M507285200","article-title":"APP1 transcription is regulated by inositol-phosphorylceramide synthase 1-diacylglycerol pathway and is controlled by ATF2 transcription factor in Cryptococcus neoformans","volume":"280","author":"L Mare","year":"2005","journal-title":"J Biol Chem"},{"issue":"2","key":"pone.0225701.ref014","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1128\/EC.00315-07","article-title":"Atf2 transcription factor binds to the APP1 promoter in Cryptococcus neoformans: stimulatory effect of diacylglycerol","volume":"7","author":"N Tommasino","year":"2008","journal-title":"Eukaryot Cell"},{"issue":"3","key":"pone.0225701.ref015","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1128\/EC.00252-10","article-title":"Role of glucose in the expression of Cryptococcus neoformans antiphagoctyic protein 1, APP1","volume":"10","author":"V Williams","year":"2011","journal-title":"Eukaryotic cell"},{"key":"pone.0225701.ref016","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2180-11-97","article-title":"Genome-wide expression profiling of the response to short-term exposure to fluconazole in Cryptococcus neoformans serotype A","volume":"11","author":"AR Florio","year":"2011","journal-title":"BMC Microbiology"},{"issue":"10","key":"pone.0225701.ref017","doi-asserted-by":"crossref","first-page":"e109863","DOI":"10.1371\/journal.pone.0109863","article-title":"9-O-butyl-13-(4-isopropylbenzyl)berberine, KR-72, is a potent antifungal agent that inhibits the growth of Cryptococcus neoformans by regulating gene expression","volume":"9","author":"S Bang","year":"2014","journal-title":"PLoS One"},{"issue":"11","key":"pone.0225701.ref018","doi-asserted-by":"crossref","first-page":"3394","DOI":"10.1128\/AAC.46.11.3394-3400.2002","article-title":"Melanization of Cryptococcus neoformans and Histoplasma capsulatum reduces their susceptibilities to amphotericin B and caspofungin","volume":"46","author":"D van Duin","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"pone.0225701.ref019","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1128\/AAC.38.11.2648","article-title":"Growth of Cryptococcus neoformans in presence of L-dopa decreases its susceptibility to amphotericin B","volume":"38","author":"Y Wang","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"pone.0225701.ref020","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1348-0421.2003.tb03395.x","article-title":"Effects of melanin upon susceptibility of Cryptococcus to antifungals","volume":"47","author":"R Ikeda","year":"2003","journal-title":"Microbiol Immunol"},{"issue":"10","key":"pone.0225701.ref021","doi-asserted-by":"crossref","first-page":"4358","DOI":"10.1128\/AAC.49.10.4358-4361.2005","article-title":"Effect of amphotericin B on capsule and cell size in Cryptococcus neoformans during murine infection","volume":"49","author":"O Zaragoza","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"pone.0225701.ref022","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01751-17","article-title":"Roles of Three Cryptococcus neoformans and Cryptococcus gattii Efflux Pump-Coding Genes in Response to Drug Treatment","volume":"62","author":"M Chang","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"pone.0225701.ref023","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1128\/AAC.05502-11","article-title":"Identification of a Cryptococcus neoformans cytochrome P450 lanosterol 14\u03b1-demethylase (Erg11) residue critical for differential susceptibility between fluconazole\/voriconazole and itraconazole\/posaconazole","volume":"56","author":"E Sionov","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"pone.0225701.ref024","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1128\/IAI.74.2.1352-1359.2006","article-title":"Role of AFR1, an ABC transporter-encoding gene, in the in vivo response to fluconazole and virulence of Cryptococcus neoformans","volume":"74","author":"M Sanguinetti","year":"2006","journal-title":"Infect Immun"},{"issue":"5","key":"pone.0225701.ref025","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1093\/jac\/dku554","article-title":"Identification and properties of plasma membrane azole efflux pumps from the pathogenic fungi Cryptococcus gattii and Cryptococcus neoformans","volume":"70","author":"LR Basso","year":"2015","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"pone.0225701.ref026","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1128\/AAC.01777-15","article-title":"Fluconazole Susceptibility in Cryptococcus gattii Is Dependent on the ABC Transporter Pdr11","volume":"60","author":"ML Yang","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"pone.0225701.ref027","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1111\/cmi.12590","article-title":"Cryptococcal therapies and drug targets: the old, the new and the promising","volume":"18","author":"C Coelho","year":"2016","journal-title":"Cell Microbiol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0225701","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,4]],"date-time":"2019-12-04T13:28:44Z","timestamp":1575466124000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0225701"}},"subtitle":[],"editor":[{"given":"Kirsten","family":"Nielsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,12,4]]},"references-count":27,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2019,12,4]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0225701","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,4]]}}}